Moleculin Biotech, Inc. financial data

Symbol
MBRX on Nasdaq
Location
Houston, TX
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 13 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 122% % -59%
Debt-to-equity -1551% % -3283%
Return On Equity 3735% %
Return On Assets -257% % -155%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 50,910,476 shares 1596%
Common Stock, Shares, Outstanding 49,498,576 shares 1549%
Entity Public Float $9,000,000 USD -44%
Common Stock, Value, Issued $49,000 USD 1533%
Weighted Average Number of Shares Outstanding, Basic 37,304,455 shares 904%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $0 USD
Research and Development Expense $15,228,000 USD -24%
General and Administrative Expense $8,872,000 USD -0.11%
Operating Income (Loss) $24,213,000 USD 16%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $51,411,000 USD -73%
Earnings Per Share, Basic -1 USD/shares 84%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $6,703,000 USD -29%
Assets, Current $7,885,000 USD -32%
Property, Plant and Equipment, Net $77,000 USD -59%
Operating Lease, Right-of-Use Asset $343,000 USD -24%
Other Assets, Noncurrent $900,000 USD
Assets $20,353,000 USD -13%
Accounts Payable, Current $2,116,000 USD -17%
Employee-related Liabilities, Current $1,352,000 USD -11%
Accrued Liabilities, Current $3,566,000 USD 17%
Liabilities, Current $5,682,000 USD 1.6%
Operating Lease, Liability, Noncurrent $258,000 USD -34%
Liabilities $47,273,000 USD 197%
Retained Earnings (Accumulated Deficit) $221,556,000 USD -46%
Stockholders' Equity Attributable to Parent $26,920,000 USD -255%
Liabilities and Equity $20,353,000 USD -13%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $4,564,000 USD 32%
Net Cash Provided by (Used in) Financing Activities $7,999,000 USD
Net Cash Provided by (Used in) Investing Activities $0 USD
Common Stock, Shares Authorized 500,000,000 shares 400%
Common Stock, Shares, Issued 49,498,576 shares 1549%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $3,438,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $6,703,000 USD -29%
Deferred Tax Assets, Valuation Allowance $38,637,000 USD 20%
Deferred Tax Assets, Gross $38,729,000 USD 19%
Operating Lease, Liability $478,000 USD -17%
Payments to Acquire Property, Plant, and Equipment $0 USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $44,973,000 USD -69%
Lessee, Operating Lease, Liability, to be Paid $566,000 USD -21%
Operating Lease, Liability, Current $132,000 USD 14%
Lessee, Operating Lease, Liability, to be Paid, Year Two $164,000 USD 3.1%
Lessee, Operating Lease, Liability, to be Paid, Year One $159,000 USD 8.9%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $88,000 USD -36%
Lessee, Operating Lease, Liability, to be Paid, Year Three $141,000 USD -14%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Unrecognized Tax Benefits $339,000 USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four $61,000 USD -57%
Operating Lease, Payments $158,000 USD 22%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $113,000 USD -12%
Deferred Tax Assets, Net of Valuation Allowance $92,000 USD -18%
Share-based Payment Arrangement, Expense $1,632,000 USD -8.2%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%